FDA Digital Health and Artificial Intelligence Glossary

The U.S. Food and Drug Administration (FDA) recently released a digital Health and Artificial Intelligence Glossary “to help support consistent use of digital health and artificial intelligence terminology by the FDA and interested parties (such as industry, digital health developers, academia, health care professionals, and patients).”  The Glossary is for educational purposes, not part of FDA guidance, policy, or recommendations.  The FDA plans to update the Glossary, and is accepting comments and questions on the Glossary – email digitalhealth@fda.hhs.gov with “Attn: DH/AI Glossary” in the subject line.